MedPath

Soybean

Generic Name
Soybean
Drug Type
Biotech
Unique Ingredient Identifier
L7HT8F1ZOD
Background

Soybean allergenic extract is used in allergenic testing.

Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy Outcomes

Early Phase 1
Withdrawn
Conditions
Maternal Obesity
Interventions
Drug: Pyrroloquinoline quinone (PQQ)
First Posted Date
2024-02-07
Last Posted Date
2025-02-13
Lead Sponsor
University of Oklahoma
Target Recruit Count
30
Registration Number
NCT06245083
Locations
🇺🇸

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition

Phase 3
Completed
Conditions
Cholestasis
Interventions
Drug: multicomponent lipid emulsion
First Posted Date
2016-01-26
Last Posted Date
2017-06-23
Lead Sponsor
Thammasat University
Target Recruit Count
44
Registration Number
NCT02663453

Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function

Phase 3
Terminated
Conditions
Intestinal Diseases
Interventions
Drug: fish oil (FO)-containing IVFE (Lipidem)
First Posted Date
2015-09-16
Last Posted Date
2018-02-28
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
13
Registration Number
NCT02550860
Locations
🇫🇷

Centre Hospitalier Lyon Sud, Pierre Bénite, France

🇫🇷

Hospices Civils de Lyon, Lyon, France

Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation

Phase 1
Completed
Conditions
Hematopoietic Stem Cell Transplantation
Interventions
First Posted Date
2015-07-31
Last Posted Date
2024-07-10
Lead Sponsor
Alexandra N. Carey
Target Recruit Count
20
Registration Number
NCT02512718
Locations
🇺🇸

Boston Children's Hospital, Boston, Massachusetts, United States

Saw Palmetto: Symptom Management for Men During Radiation Therapy

Phase 1
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2012-04-25
Last Posted Date
2019-09-30
Lead Sponsor
Michigan State University
Target Recruit Count
48
Registration Number
NCT01585246
Locations
🇺🇸

St. Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

🇺🇸

Allegiance Health, Jackson, Michigan, United States

🇺🇸

McLaren Macomb, Mount Clemens, Michigan, United States

and more 3 locations

Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition

Phase 3
Terminated
Conditions
Total Parenteral Nutrition-induced Cholestasis
Interventions
First Posted Date
2012-03-28
Last Posted Date
2016-05-12
Lead Sponsor
Johane Allard
Target Recruit Count
2
Registration Number
NCT01565278
Locations
🇨🇦

St Boniface Hospital, Winnipeg, Manitoba, Canada

🇨🇦

Foothills Medical Center, Calgary, Alberta, Canada

🇨🇦

University of Alberta, Edmonton, Alberta, Canada

and more 1 locations

Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation

Phase 3
Completed
Conditions
Atrial Fibrillation
Interventions
First Posted Date
2010-11-05
Last Posted Date
2022-03-17
Lead Sponsor
Montreal Heart Institute
Target Recruit Count
337
Registration Number
NCT01235130
Locations
🇨🇦

Montreal Heart Institute Coordinating Center, Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath